Skip to Main Content

Paper Details

Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Int J Mol Sci
13
2021
Author NameAffiliation
Thomas CluzeauUniversity Hospital of Nice, Cote d'Azur University
Thomas CluzeauINSERM U1065, Cote d'Azur University
Thomas Cluzeau
  • 1 - 3

Datasets

Release 1.2